StonvexLoading…
StonvexStonvexStonvexCore line items from TRGP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Q2 2024 2024-06-30 | Q1 2024 2024-03-31 | Annual 2023 2023-12-31 |
|---|---|---|---|---|
Revenue | $14.14B | $7.04B | $3.99B | $13.52B |
Operating Income | $2.70B | $1.27B | $639.40M | $2.63B |
Net Income | $1.31B | $573.70M | $275.20M | $1.35B |
EPS (Diluted) | $5.74 | $2.55 | $1.22 | $3.66 |
Total Assets | $22.73B | $21.26B | $20.85B | $20.67B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $157.30M | $166.40M | $109.90M | $141.70M |
Free Cash Flow OCF − CapEx | $683.90M | $370.80M | $206.60M | $826.20M |
Shares Outstanding | 217.76M | 219.17M | 222.15M | 222.61M |